Unknown

Dataset Information

0

Long-Term Kinetics of SARS-CoV-2 Neutralizing and Anti-Receptor Binding Domain Antibodies among Laboratory-Confirmed COVID-19 Cases in Delhi National Capital Region, India: A Prospective, One-Year Follow-Up Study.


ABSTRACT: Background: This study was conducted with the objective of measuring the neutralizing and anti-receptor binding domain antibody levels against SARS-CoV-2 among laboratory-confirmed COVID-19 cases and exploring its long-term kinetics over a period of 1 year. Methods: One hundred laboratory-confirmed COVID-19 cases were recruited. Serum samples of the participants were collected within three months from the date of the positive COVID-19 report. The participants were prospectively followed up every three months for symptoms and the collection of blood samples for three additional rounds. The presence of anti-SARS-CoV-2 antibodies (IgA, IgG, and IgM antibodies), anti-receptor binding domain antibodies (anti-RBD), and neutralizing antibodies were measured. Findings: Median plaque reduction neutralization test (PRNT) titers showed a rising trend in the first three rounds of follow-up. The quantitative anti-receptor binding domain ELISA (QRBD) values showed a declining trend in the initial three rounds. However, both the PRNT titers and QRBD values showed significantly higher values for the fourth round of follow-up. Total antibody (WANTAI) levels showed an increasing trend in the initial three rounds (statistically significant). Interpretation: Neutralizing antibodies showed an increasing trend. The anti-receptor binding domain antibodies showed a decreasing trend. Neutralizing antibodies and anti-RBD antibodies persisted in the majority.

SUBMITTER: Misra P 

PROVIDER: S-EPMC10856624 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Long-Term Kinetics of SARS-CoV-2 Neutralizing and Anti-Receptor Binding Domain Antibodies among Laboratory-Confirmed COVID-19 Cases in Delhi National Capital Region, India: A Prospective, One-Year Follow-Up Study.

Misra Puneet P   Medigeshi Guruprasad R GR   Kant Shashi S   Jaiswal Abhishek A   Ahmad Mohammad M   Rahman Anisur A   Guleria Randeep R   Rai Sanjay Kumar SK   Deori Trideep Jyoti TJ   Mandal Suprakash S   Gongal Gaurav G   Bairwa Mohan M   Haldar Partha P   Kumar Rakesh R   Garg Neha N  

Journal of clinical medicine 20240129 3


<b>Background:</b> This study was conducted with the objective of measuring the neutralizing and anti-receptor binding domain antibody levels against SARS-CoV-2 among laboratory-confirmed COVID-19 cases and exploring its long-term kinetics over a period of 1 year. <b>Methods:</b> One hundred laboratory-confirmed COVID-19 cases were recruited. Serum samples of the participants were collected within three months from the date of the positive COVID-19 report. The participants were prospectively fol  ...[more]

Similar Datasets

| S-EPMC9412620 | biostudies-literature
| S-EPMC10826300 | biostudies-literature
| S-EPMC5282768 | biostudies-literature
| S-EPMC9017938 | biostudies-literature
| S-EPMC6874269 | biostudies-literature
| S-EPMC4855960 | biostudies-literature
| S-EPMC7538367 | biostudies-literature
| S-EPMC8477491 | biostudies-literature
| S-EPMC10685658 | biostudies-literature
| S-EPMC5523534 | biostudies-other